| Literature DB >> 33291793 |
Elisabetta Caselli1, Maria D'Accolti1, Francesca Caccuri2, Irene Soffritti1, Valentina Gentili1, Daria Bortolotti1, Antonella Rotola1, Enzo Cassai1, Simona Fiorentini2, Alberto Zani2, Arnaldo Caruso2, Roberta Rizzo1, Dario Di Luca3.
Abstract
Human herpesvirus 6 (HHV-6) is a β-herpesvirus that is highly prevalent in the human population. HHV-6 comprises two recognized species (HHV-6A and HHV-6B). Despite different cell tropism and disease association, HHV-6A/B show high genome homology and harbor the conserved U94 gene, which is limited to HHV-6 and absent in all the other human herpesviruses. U94 has key functions in the virus life cycle and associated diseases, having demonstrated or putative roles in virus replication, integration, and reactivation. During natural infection, U94 elicits an immune response, and the prevalence and extent of the anti-U94 response are associated with specific diseases. Notably, U94 can entirely reproduce some virus effects at the cell level, including inhibition of cell migration, induction of cytokines and HLA-G expression, and angiogenesis inhibition, supporting a direct U94 role in the development of HHV-6-associated diseases. Moreover, specific U94 properties, such as the ability to modulate angiogenesis pathways, have been exploited to counteract cancer development. Here, we review the information available on this key HHV-6 gene, highlighting its potential uses.Entities:
Keywords: U94 exploitation; U94 functions; human herpesvirus 6
Mesh:
Substances:
Year: 2020 PMID: 33291793 PMCID: PMC7762089 DOI: 10.3390/cells9122608
Source DB: PubMed Journal: Cells ISSN: 2073-4409 Impact factor: 6.600